Generated by All in One SEO v4.9.8, this is an llms.txt file, used by LLMs to index the site.

# ContextVision

## Sitemaps

- [XML Sitemap](https://www.contextvision.se/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [ContextVision Q1 Interim report 2026](https://www.contextvision.se/contextvision-q1-interim-report-2026/) - Solid progress and disciplined execution in a stabilising market The first quarter of 2026 reflects continued execution in a stabilising market, alongside solid progress toward data-driven quantitative imaging. As part of our ongoing development, we strengthened our leadership team with the appointment of Marco Marien Voormolen as Chief Technology Officer. In parallel, we announced a
- [ContextVision Year-end Report 2025](https://www.contextvision.se/contextvision-year-end-report-2025/) - Substantial progress in transformation amid early signs of stabilization During the fourth quarter and the conclusion of 2025, ContextVision continued to navigate a challenging market environment while making important and decisive progress in our strategic transformation. Despite ongoing global uncertainty, we strengthened our long-term position through a major milestone in Data Quality, marked by the
- [ContextVision Q3 Interim Report 2025](https://www.contextvision.se/contextvision-q3-interim-report-2025/) - Navigating market uncertainty while making solid progress with our Data Quality initiative During the third quarter, we continued to experience a turbulent market, as our customers faced ongoing price pressure and trade-related challenges, leading to general uncertainty and hesitation. While navigating these complex market dynamics, we made solid progress with our Data Quality initiative as
- [ContextVision’s Impact on Data Quality: From Images to Insights](https://www.contextvision.se/contextvisions-impact-on-data-quality-from-images-to-insights/) - Discover new perspectives on how Data Quality is transforming medical imaging. ContextVision invites you for a first-hand look at current and future opportunities this transition creates - from sharper visuals to actionable insights. With more than 40 years of leadership in medical image enhancement, ContextVision is advancing its legacy through the transformation to Data Quality
- [Precision Control for Ultrasound Image Quality: The New Tuning Interface Plus](https://www.contextvision.se/precision-control-for-ultrasound-image-quality-the-new-tuning-interface-plus/) - ContextVision presents a powerful API-driven application designed to give ultrasound OEMs full control over image quality — enabling fast, precise, and in-house fine-tuning of enhancement parameters. Learn why continuous image quality matters.From images to insights: ContextVision has more than 40 years of leadership in medical image enhancement, with a dedicated team constantly driving innovation. We
- [The Intelligent Resolution Enhancement – Introducing a ContextVision Innovation](https://www.contextvision.se/the-intelligent-resolution-enhancement-introducing-a-contextvision-innovation/) - Sharper Ultrasound Imaging with True Anatomical Representation: ContextVision will showcase its latest breakthrough at RSNA 2025 — an intelligent resolution feature that restores anatomical accuracy while elevating visual clarity. Here are five key things to know about the innovation and the event in Chicago. 1. Background: The Clinical Imaging Challenge Ultrasound images often lose clarity
- [ContextVision Q2 Interim Report 2025](https://www.contextvision.se/contextvision-q2-interim-report-2025/) - Customers pressured by trade uncertainty – We continue to invest to build tomorrow’s solutions During the quarter our customers faced uncertainties related to terms of global trade and supply chains, which have led some customers to delay purchasing decisions. This has been particularly noticeable in Asia, where a combination of economic and political factors has
- [ContextVision AB: Q2 interim report 2025 – Customers pressured by trade uncertainty – We continue to invest to build tomorrow’s solutions](https://www.contextvision.se/contextvision-ab-q2-interim-report-2025-customers-pressured-by-trade-uncertainty-we-continue-to-invest-to-build-tomorrows-solutions/) - Q2 Highlights Parterships signed with the University of Waterloo and ultrasound technology expert InPhase Solutions AS to advance ultrasound diagnostics for MASLD Partnership signed with AMRA Medical to enable correlations between MRI and ultrasound imaging biomarkers Attended the CMEF Conference in Shanghai with further discussions with potential customers New customer signed in Asia within Specialty
- [ContextVision publishes Webcast for the Q2 report 2025](https://www.contextvision.se/contextvision-publishes-webcast-for-the-q2-report-2025/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2025 along with the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.se/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a software company specialized
- [ContextVision publishes Webcast for the Q2 report 2025](https://www.contextvision.se/contextvision-publishes-webcast-for-the-q2-report-2025-2/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2025 along with the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.se/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a software company specialized
- [ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics](https://www.contextvision.se/contextvision-and-amra-medical-join-forces-to-advance-multimodal-imaging-in-liver-disease-diagnostics/) - The collaboration expands upon ContextVision’s ongoing Data Quality initiative to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. The joint effort builds on ContextVision’s strategic clinical partnership with the University of Washington (USA), where a clinical evaluation is underway to acquire imaging data for the development of a multiparameter biomarker for
- [Bulletin from the annual general meeting of  ContextVision AB (publ)](https://www.contextvision.se/bulletin-from-the-annual-general-meeting-of-contextvision-ab-publ/) - At the annual general meeting of ContextVision AB (publ) held on May 13, 2025, the following decisions were made: Adoption of the income statement and the balance sheet The general meeting resolved to adopt the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet. Dividend The
- [ContextVision partners with University of Waterloo in Canada and InPhase Solutions AS in Norway to advance ultrasound diagnostics for MASLD](https://www.contextvision.se/contextvision-partners-with-university-of-waterloo-in-canada-and-inphase-solutions-as-in-norway-to-advance-ultrasound-diagnostics-for-masld/) - ContextVision, a global leader in medical imaging solutions, is strengthening its research ecosystem by establishing key partnerships with ultrasound data scientists and clinical experts. These collaborations will accelerate the development of ContextVision’s AI-based solutions capable of interpreting organ-specific ultrasound imaging datasets, with a first focus on optimizing data quality for the diagnosis of metabolic dysfunction-associated
- [ContextVision publishes Webcast for the Q1 report 2025](https://www.contextvision.se/contextvision-publishes-webcast-for-the-q1-report-2025/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q1 2025 along with the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.se/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a software company specialized in
- [ContextVision AB: Q1 interim report 2025 – Executing on our strategy for Image Quality and Data Quality](https://www.contextvision.se/contextvision-ab-q1-interim-report-2025-executing-on-our-strategy-for-image-quality-and-data-quality/) - Q1 highlights Partnership signed with the University of Washington as we progress our aim to develop organ-specific digital biomarkers Investments in ultrasound equipment to support our clinical research in the U.S. Attended the ECR Conference with high interest from current and potential customers Fruitful collaborations with customers to support a larger part of the image
- [ContextVision Q1 Interim Report 2025](https://www.contextvision.se/contextvision-q1-report-2025/) - Executing on our strategy for Image Quality and Data Quality The first quarter of the year has been eventful from many perspectives. Global macroeconomic factors continue to create uncertainty in the market, combined with an unfavorable seasonality for us. Despite this, we remain firmly committed to executing on our long-term strategy, with new partnerships within
- [ContextVision publishes annual report for the fiscal year 2024](https://www.contextvision.se/contextvision-publishes-annual-report-for-the-fiscal-year-2024/) - The annual report of ContextVision for the fiscal year 2024 is now available at www.contextvision.com. The annual report is a summary of the past year as well as an overview of the company's development and progress. The annual report is available in both Swedish and English versions. The report is best suited for reading on screen.
- [NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)](https://www.contextvision.se/notice-to-the-annual-general-meeting-in-contextvision-ab-publ/) - The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Annual General Meeting on Tuesday, 13 May 2025, at 14:00, at the company's premises, Gamla Brogatan 26, Stockholm. Participation and Notification etc Shareholders who wish to participate in the general meeting with the right to vote shall be recorded as shareholder
- [ContextVision Presentation Q1 2022](https://www.contextvision.se/contextvision-presentation-q1-2022/) - ContextVision’s CEO Ola Lindblad will present the highlights for the first quarter 2022, followed by a Q&A session. Hosted by SpareBank 1 Markets Time: 22. April 2022 at 12.00 CET Register below: https://attendee.gotowebinar.com/register/4705777148155319566
- [Join us at CMEF 2025](https://www.contextvision.se/join-us-at-cmef-2025/) - With the latest technology and specialized team, we customize every solution to enhance the image quality of medical images, leading to faster and more reliable diagnostics for patients worldwide. Visit our booth at CMEF 2025 to discuss how we can transform the future of healthcare – together.
- [Join us at ECR 2025](https://www.contextvision.se/ecr-2025/) - BEYOND IMAGING AI-powered solutions enabling precision diagnosis Join us at ECR 2025 With the latest technology and specialized team, we customize every solution to enhance the image quality of medical images, leading to faster and more reliable diagnostics for patients worldwide. Visit our booth at ECR 2025 to discuss how we can transform the future
- [ContextVision AB: Year-end Report 2024 – Progress in Data Quality and growing interest](https://www.contextvision.se/contextvision-ab-year-end-report-2024-progress-in-data-quality-and-growing-interest-2/) - Q4 highlights Attended the RSNA Conference in Chicago and launched two products. Ongoing discussions about collaborations with key customers, including tier 1 OEMs. Strong interest in the industry regarding quantitative imaging – reinforcing our strategy. Continued progress within Data Quality – now conducting tests, measurements and experiments. Share buy-back of approximately 1.2 million shares at
- [ContextVision publishes Webcast for the Year-end Report 2024](https://www.contextvision.se/contextvision-publishes-webcast-for-the-year-end-report-2024/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q4 2024 along with the financials for the quarter and full year. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.se/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a medical
- [ContextVision Year-end Report 2024](https://www.contextvision.se/contextvision-year-end-report-2024/) - Progress in Data Quality and growing interest During the last quarter of 2024, we made continued progress in our Data Quality venture, with increasing industry interest confirming its transformative potential. At the same time, we are advancing discussions with key customers on strategic partnerships within Image Quality. These efforts set the stage for continued success
- [Watch ContextVision’s CEO and CTO discuss the potential of Data Quality](https://www.contextvision.se/watch-contextvisions-ceo-and-cto-discuss-the-potential-of-data-quality/) - In an interview, CEO Gerald Pötzsch and CTO Gunnar Läthén discuss how ContextVision’s cutting-edge technology is set to revolutionize medical diagnostics and drive innovation through Data Quality. Watch the interview here: https://www.youtube.com/watch?v=JjRl47tnAHQ For more information, please contact Gerald Pötzsch Chief Executive Officer, ContextVision gerald.potzsch@contextvision.com About ContextVision ContextVision is a medical technology software company specialized in
- [Join us at RSNA 2024](https://www.contextvision.se/join-us-at-rsna-2024/) - BEYOND IMAGING Transforming data into diagnostic power North Hall B, Level 3Booth #6802Dec. 1–4, Chicago/USA We have some exciting product news to demonstrate this year. With the latest technology and specialized team, we customize every solution to enhance the image quality of medical images, leading to faster and more reliable diagnostics for patients worldwide. Visit
- [ContextVision & The Pathologist's INIFY webinar – now with on-demand access](https://www.contextvision.se/contextvision-and-the-pathologist-to-co-host-inify-webinar/) - On March 25, 16:00 CET (15:00 GMT), ContextVision and The Pathologist teamed up to host a free webinar: "Experience and results from using INIFY® Prostate Screening – in the fully digitalized pathology workflow at Cannizzaro Hospital, Italy". Here, Dr Filippo Fraggetta shared his experience of using INIFY Prostate Screening, as well as preliminary results from the hospital's ongoing clinical study. Now available on demand – register here for access.
- [ContextVision and the University of Washington sign a partnership agreement to advance liver disease diagnosis](https://www.contextvision.se/contextvision-and-the-university-of-washington-sign-a-partnership-agreement-to-advance-liver-disease-diagnosis-2/) - ContextVision, a global market leader in medical imaging solutions, has partnered with the University of Washington, a top ten university that is globally recognized for its research and clinical excellence. The university’s healthcare system, UW Medicine, brings significant clinical expertise and research capabilities to this collaboration. At the end of 2023, ContextVision launched a strategic
- [ContextVision Webcast Q3 2023](https://www.contextvision.se/webcast-q3-2023/) - ContextVision Q3 report Q&A interview: Record topline growth and strong margins With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong performance is driven by a healthy core business supported by investments in growth initiatives such
- [ContextVision Webcast Q4 2023](https://www.contextvision.se/webcast-q4-2023/) - Year-end report 2023 – Underlying growth and scaling up the business 2023 has been a dynamic year, concluding a highly active final quarter. This year we achieved record Q2 and Q3 net sales, and now we round up with record Q4 net sales as well. In the last quarter, we released a new innovative X-ray
- [ContextVision Webcast Q1 2024](https://www.contextvision.se/webcast-q1-2024/) - Building for the future and leading innovation As we step into 2024, we have actively been laying the foundations for the future. Our presence at the European Congress of Radiology (ECR) has opened doors to new promising customer relationships, while internally, we’re fine-tuning our processes for greater agility in product releases. We are also continuing
- [ContextVision Q3 Interim Report 2024](https://www.contextvision.se/webcast-q3-2024/) - Focus on internal efficiency and product development to drive long-term growth During the third quarter of 2024, we focused on several key initiatives crucial to our continued progress. We continued the integration with our new customers in Asia and North America, as well as strengthened our internal teams. Additionally, we are working closely with the
- [ContextVision Q2 interim report 2024](https://www.contextvision.se/webcast-q2-2024/) - Strong cash position supports continued investment in Image and Data Quality In the second quarter of 2024, we have signed new customers in North America and Asia, and we are continuing our investments in both image quality and data quality. Our cash flow remains stable, with a good cash position, and we are confident that
- [ContextVision publishes Webcast for Q3 2024](https://www.contextvision.se/contextvision-publishes-webcast-for-q3-2024/) - ContextVision Q3 report Q&A interview: Record topline growth and strong margins With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong performance is driven by a healthy core business supported by investments in growth initiatives such
- [Annual report 2022 – record sales with full focus on growing the core business](https://www.contextvision.se/annual-report-2022-record-sales-with-full-focus-on-growing-the-core-business/) - STOCKHOLM – March 30th, 2023- ContextVision, a medical technology software company specializing in image processing and image analysis, today presents their Annual Report for 2022. The Annual Report gives additional information about the record year, where net sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%. 2022 was also
- [Year-end report 2023 – Underlying growth and scaling up the business](https://www.contextvision.se/contextvision-ab-year-end-report-2023-underlying-growth-and-scaling-up-the-business/) - Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) Increasing interest from customers and OEMs in our products Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data Record Q4 Net Sales of 33.2
- [Q1 interim report 2024 – Building for the future and leading innovation](https://www.contextvision.se/contextvision-ab-q1-interim-report-2024-building-for-the-future-and-leading-innovation/) - Q1 Highlights Participation in the European Congress of Radiology in Vienna meeting new potential customers and following up on previous discussions with potential customers. Celebrating 25 years of partnership with a customer, underscoring our commitment to long-lasting relationships and techological leadership. Rebuilding of the internal product development structure to enable faster and more frequent product
- [Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth](https://www.contextvision.se/q3-interim-report-2024-focus-on-internal-efficiency-and-product-development-to-drive-long-term-growth/) - Q3 Highlights Continuing integration with newly signed customers in Asia and North America. Close collaboration with the market to receive feedback from customers to strategically develop and enhance our products. Internal reorganization to strenghen our teams and become more effective regarding marketing and product development. Execution of roadmap for upcoming products. Q3 Financial Data Net
- [ContextVision AB: Q2 interim report 2024 - Strong cash position supports continued investment in Image and Data Quality](https://www.contextvision.se/contextvision-ab-q2-interim-report-2024-strong-cash-position-supports-continued-investment-in-image-and-data-quality/) - Q2 Highlights New customers signed in Asia and North America. ContextVision now has potential to expand its footprint in North America in different segments. Stable cash flow and good cash position enable continued investments in image quality and in data quality. Progress in Point-of-Care Ultrasound (POCUS) as ContextVision enters early stages of the development of
- [ContextVision publishes annual report for the fiscal year 2023](https://www.contextvision.se/contextvision-publishes-annual-report-for-the-fiscal-year-2023/) - The annual report is available in both Swedish and English versions. The report is best suited for reading on screen. Printed copies can be ordered via ir@contextvision.com ContextVision also registers the ESEF version (European Single Electronic Format) of the annual report for 2023 with the Swedish Financial Supervisory Authority. For more information, please contact: Richard
- [Correction: ContextVision AB: Result of the offer to buy back own shares](https://www.contextvision.se/correction-contextvision-ab-result-of-the-offer-to-buy-back-own-shares/) - Stockholm, Dec 18, 2024 A correction is made to the press release published today, December 18, 2024, at 08.10 AM, regarding the number of shares resolved to be bought back by the company. A number of 35,722 shares were not included in the previous press release, the correct press release is as follows. Reference is
- [ContextVision AB: Result of the offer to buy back own shares](https://www.contextvision.se/contextvision-ab-result-of-the-offer-to-buy-back-own-shares/) - NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. Stockholm, Dec 18, 2024 Reference is made to the stock exchange announcement on December 13th, 2024, in which ContextVision AB (publ) (“ContextVision”
- [ContextVision AB: Launch of offer to buy back own shares](https://www.contextvision.se/contextvision-ab-launch-of-offer-to-buy-back-own-shares/) - NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. Stockholm, Dec 13, 2024 ContextVision AB (publ) (“ContextVision” or the “Company”) hereby launches an offer to buy back up to 3,000,000 shares
- [ContextVision distributes cash dividend of SEK 0.30 per share](https://www.contextvision.se/contextvision-distributes-cash-dividend-of-sek-0-30-per-share/) - On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of this background and in line with the board’s recommendation, the Meeting resolved on a dividend
- [ContextVision shows strong momentum in Q4, leading to record sales for the year](https://www.contextvision.se/contextvision-shows-strong-momentum-in-q4-leading-to-record-sales-for-the-year/) - STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow
- [ContextVision confirms the value of the upcoming dividend](https://www.contextvision.se/contextvision-confirms-the-value-of-the-upcoming-dividend/) - Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15, 2021, the company confirms that the value of the dividend distribution in form of the
- [ContextVision announces resolution regarding record date for dividend](https://www.contextvision.se/contextvision-announces-resolution-regarding-record-date-for-dividend/) - Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB ("ContextVision" or the "Company") held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 ("INIFY") to the shareholders of the Company. The board of directors has determined the record date for
- [ContextVision Extraordinary General Meeting](https://www.contextvision.se/contextvision-extraordinary-general-meeting/) - On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm. The Board's proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital Pathology to the shareholders of ContextVision AB, was approved. No other matters were processed at
- [ContextVision – Invitation to Annual General Meeting 2022](https://www.contextvision.se/contextvision-invitation-to-annual-general-meeting-2022/) - STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail: markush@contextvision.se
- [ContextVision Annual General Meeting](https://www.contextvision.se/contextvision-annual-general-meeting/) - On the 4th of May 2022, ContextVision held its ordinary Shareholders' Annual General Meeting in Stockholm. Major items approved by the Annual General Meeting include: The annual financial report regarding 2021 was approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and
- [ContextVision – Invitation to Annual General Meeting 2023](https://www.contextvision.se/contextvision-invitation-to-annual-general-meeting-2023/) - STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail: markush@contextvision.se
- [Notice to Attend the Annual General Meeting in ContextVision AB (publ)](https://www.contextvision.se/notice-to-attend-the-annual-general-meeting-in-contextvision-ab-publ/) - Notification etc Shareholders who wish to participate in the annual general meeting with the right to vote shall be recorded as shareholder in the share register kept by Euroclear Sweden AB on May 3, 2024, temporary registration for shareholders registered at Norska Verdipapirsentralen (VPS) is made by DNB Bank ASA, see below; and give notice
- [Bulletin from the Annual General Meeting of ContextVision AB (publ) on 14 May 2024](https://www.contextvision.se/bulletin-from-the-annual-general-meeting-of-contextvision-ab-publ-on-14-may-2024/) - Adoption of the accounts The Annual General Meeting approved the Company's income statement and balance sheet for 2023. The Board members and the Managing Director were discharged from liability for the fiscal year 2023. Disposition of profits The Annual General Meeting resolved, in accordance with the Board's proposal, that this year's results shall be carried
- [Notice to the Extraordinary General Meeting in ContextVision AB (publ)](https://www.contextvision.se/notice-to-the-extraordinary-general-meeting-in-contextvision-ab-publ/) - The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Extraordinary General Meeting on Wednesday, 20 November 2024, at 11:00, at the company's premises, Holländargatan 13, Stockholm. Participation and Notification etc Shareholders who wish to participate in the general meeting with the right to vote shall be recorded as shareholder in
- [Bulletin from the extraordinary general meeting of ContextVision AB (Publ)](https://www.contextvision.se/bulletin-from-the-extraordinary-general-meeting-of-contextvision-ab-publ/) - At the Extraordinary General Meeting of ContextVision AB (publ) held on November 20, 2024, the following decisions were made: Authorization for the Board of Directors to resolve on the acquisition of the company’s own shares The General Meeting resolved in accordance with the Board of Directors’ proposal on an authorization for the Board of Directors
- [ContextVision – Mandatory notification of trade – primary insider](https://www.contextvision.se/contextvision-mandatory-notification-of-trade-primary-insider/) - STOCKHOLM – November 02 2022 – Gerald Pötzsch, CEO of ContextVision, has during the period of August 31st until November 1st, 2022 purchased 10.000 shares in ContextVision AB at an average price of NOK 8,71 per share. After the transaction, Mr Pötzsch holds a total of 15.000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly
- [ContextVision – Mandatory notification of trade – primary insider](https://www.contextvision.se/contextvision-mandatory-notification-of-trade-primary-insider-4/) - STOCKHOLM – May 16 2022 – Markus Hökerberg, CFO of ContextVision, has on May 13th, 2022 purchased 9,562 shares in ContextVision AB at an average price of NOK 7.80 per share. After the transaction, Mr Hökerberg holds a total of 9,562 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"),
- [ContextVision – Mandatory notification of trade – primary insider](https://www.contextvision.se/contextvision-mandatory-notification-of-trade-primary-insider-3/) - STOCKHOLM – August 11 2022 – Markus Hökerberg, CFO of ContextVision, has on August 11th, 2022 purchased 7,000 shares in ContextVision AB at an average price of NOK 9.80 per share. After the transaction, Mr Hökerberg holds a total of 16,562 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"),
- [Mandatory notification of trade – primary insider](https://www.contextvision.se/contextvision-mandatory-notification-of-trade-primary-insider-5/) - Gerald Pötzsch, CEO of ContextVision, has between May 8th and May 10th, 2024, purchased 10.000 shares in ContextVision AB at an average price of NOK 6,02 per share. After the transaction, Mr. Pötzsch holds a total of 35.000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider
- [Mandatory notification of trade – primary insider](https://www.contextvision.se/mandatory-notification-of-trade-primary-insider/) - With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Olof Sandén Relation to listed entity: Chairman of the Board Trade: 15.000 shares Date: 08.11.2024 Average purchase price: NOK 4,83 per share Primary
- [Mandatory notification of trade – primary insider](https://www.contextvision.se/mandatory-notification-of-trade-primary-insider-2/) - Martin Hedlund, member of the Board of ContextVision has purchased shares in ContextVision. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Martin Hedlund Relation to listed entity:
- [ContextVision publishes Webcast for Q2 2024](https://www.contextvision.se/contextvision-publishes-webcast-for-q2-2024/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2024 along the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a medical technology software company specialized
- [ContextVision enters Data Quality market with organ-specific enhancements](https://www.contextvision.se/contextvision-enters-data-quality-market-with-organ-specific-enhancements/) - Expanding product pipeline from Image Quality to Data Quality ContextVision is committed to expanding its Image Quality business, which today focuses on enhancing medical image quality for a radiologists’ interpretation. Alongside, ContextVision is pioneering a new Data Quality business aimed at machine-aided interpretation. Data Quality is a natural extension of ContextVision’s Image Quality business that
- [Strong second quarter with solid margin growth](https://www.contextvision.se/strong-second-quarter-with-solid-margin-growth/) - "Our impressive performance was fuelled by the excellent licensing sales in our core business and boosted by favourable foreign exchange rates. We anticipate our margins to remain stable, consistently reaching a high level of 40 in the foreseeable future", says Gerald Pötzsch, CEO of ContextVision. In the second quarter, net sales amounted to SEK 33.6
- [New CFO appointed](https://www.contextvision.se/new-cfo-appointed/) - Stockholm, August 28th, 2023 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Richard Hallström as a Chief Financial Officer (CFO), effective today 28th of August. He succeeds Markus Hökerberg, who has acted as an Interim CFO. Mr. Hallström previously served as CFO at ScandiNova Systems and prior to
- [Record topline growth and strong margins](https://www.contextvision.se/record-topline-growth-and-strong-margins/) - STOCKHOLM – October 26, 2023. In Q3, ContextVision achieved an unprecedented high in net sales, totaling SEK 32.8M (25.6), which adds yet another record-breaking quarter. Additionally, net sales for the first nine months also reached a new record at SEK 99.0M (85.3). During Q3, ContextVision's EBITDA amounted to SEK 14.5M (13.3), and for the first
- [ContextVision publishes Webcast for Q1 2024](https://www.contextvision.se/contextvision-publishes-webcast-for-q1-2024/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q1 2024 along the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is a medical technology software company specialized
- [ContextVision Announces New Image Quality Advancements in X-Ray](https://www.contextvision.se/contextvision-announces-new-image-quality-advancements-in-x-ray/) - With solutions spanning ultrasound, X-ray, and MRI, ContextVision’s cutting-edge image enhancement software is designed to deliver unparalleled image clarity, empowering medical professionals worldwide. At the forefront of their showcase is the enhanced Altumira™ series – a software solution for X-ray imaging. Powered by AI, Altumira™ for static imaging now features a new, impressive scatter correction
- [Stable Q3 sales and very strong first nine months of 2022](https://www.contextvision.se/stable-q3-sales-and-very-strong-first-nine-months-of-2022/) - Our Q3 revenues came in at 26.9 MSEK compared to 26.0 in last year, down 3 % from last year. Currencies played a role and had a positive impact of 7MSEK. Our comparison quarter in 2021 was exceptionally strong due to one off bookings that was done during that quarter. Our 9 months revenue came
- [ContextVision publishes Webcast for Q4 2023](https://www.contextvision.se/contextvision-publishes-webcast-for-q4-2023/) - Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision's highlights from Q4 2023 along the financials for the quarter and full year. The Webcast is available on ContextVision's website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision's CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVision ContextVision is
- [ContextVision Showcases Its Product Altumira™ — The World-leading Image Quality in Radiography — Now Even More Powerful](https://www.contextvision.se/contextvision-showcases-its-product-altumira-the-world-leading-image-quality-in-radiography-now-even-more-powerful/) - ContextVision offers solutions for ultrasound, X-ray and MRI. With a core business focus on image enhancement software designed to deliver unprecedented image quality, ContextVision is the global market leader and partner to leading OEMs, with solutions installed worldwide in more than 450,000 systems. Thanks to its superior imaging quality, ContextVision's technology leads to more rapid
- [From Pioneers to Luminaries — ContextVision Celebrates 40 years of Excellence and Aims for the Future](https://www.contextvision.se/from-pioneers-to-luminaries-contextvision-celebrates-40-years-of-excellence-and-aims-for-the-future/) - Taking AI and machine learning to whole new fields When it comes to applying artificial intelligence (AI) and machine learning to medical imaging, ContextVision has always been ahead of its field. Over the last decades, the company’s pioneering technologies have evolved into a highly sophisticated portfolio of solutions for Ultrasound’s, X-ray’s, MRI’s, and more. Altumira
- [Hello world!](https://www.contextvision.se/hello-world/) - Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
- [Hello world!](https://www.contextvision.se/hello-world/) - Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
- [ContextVision AB - Key information relating payment of cash dividend * Correction](https://www.contextvision.se/contextvision-ab-key-information-relating-payment-of-cash-dividend-correction/) - Tranche 1 Dividend amount: SEK 0.15 per share Declared currency: SEK Last day including right: 5 May 2023 Ex-date: 8 May 2023 *Correction: Record date: 9 May 2023 Payment date: on or about 16 May 2023 Date of approval: 3 May 2023 Tranche 2 Dividend amount: SEK 0.15 per share Declared currency: SEK Last day
- [Continued strong growth](https://www.contextvision.se/continued-strong-growth/) - STOCKHOLM – April 27th, 2023 - ContextVision, a medical technology software company specializing in image processing and image analysis, today proudly presents their Q1 Report for 2023. The robust growth continues and in the first quarter of 2023 the company saw a revenue of SEK 32.4 M (27.2), an increase of 19% and an EBITDA of
- [Strong Q4 and a record full year 2022](https://www.contextvision.se/strong-q4-and-a-record-full-year-2022/) - STOCKHOLM – Feb 16, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fourth quarter results. Net sales record The company delivers another record quarter with a net sales of SEK 32.6 M, an increase of 19%. For the full year, net sales increased 20% to
- [Let’s get closer – at RSNA 2022](https://www.contextvision.se/lets-get-closer-at-rsna-2022/) - Visit our booth to discuss how we can push the limits of image quality in ultrasound and X-ray – together.
- [ContextVision – Mandatory notification of trade – primary insider](https://www.contextvision.se/contextvision-mandatory-notification-of-trade-primary-insider-2/) - STOCKHOLM – October 26 2022 – Markus Hökerberg, CFO of ContextVision, has during October 20-26, 2022 purchased 11,600 shares in ContextVision AB at an average price of NOK 8.71 per share. After the transaction, Mr Hökerberg holds a total of 28,162 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the
- [Successfully focusing on core business](https://www.contextvision.se/successfully-focusing-on-core-business/) - STOCKHOLM – 12 of August 2022 – ContextVision, a medical technology software company specializing in image processing, delivered the Company’s best ever second quarter revenue numbers and a significant EBITDA increase. Sales in the second quarter reached MSEK 32,5 (24.4), an 19% increase compared with the previous quarter, and an increase of 26% versus last year’s
- [See you at ECR 2022](https://www.contextvision.se/see-you-at-ecr-2022/) - Will we be meeting at ECR this year? You will find us at Expo X4/Booth 437 between July 13–17 both in Vienna/Austria and Online.
- [ContextVision announces appointment of Gerald Pötzsch as new CEO](https://www.contextvision.se/contextvision-announces-appointment-of-gerald-potzsch-as-new-ceo/) - ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Gerald Pötzsch as Chief Executive Officer, effective 1st of August 2022. Gerald has solid academic and professional background, holding doctor’s degrees both in Engineering and Medicine and 16 years with Philips Medical imaging business. “This will be a good addition to
- [Exiting quarter and strong demand going forward](https://www.contextvision.se/exiting-quarter-and-strong-demand-going-forward/) - The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8). “It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical Imaging business. During the quarter we signed both new customers as well as extended several
- [ContextVision presents Annual Report 2021](https://www.contextvision.se/contextvision-presents-annual-report-2021/) - STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: finance@contextvision.se For inquiries, please contact CFO Markus Hökerberg E-mail: markush@contextvision.se ### About ContextVision ContextVision is a medical technology software company
- [ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO](https://www.contextvision.se/contextvision-announces-new-leadership-team-appoints-ola-lindblad-as-ceo/) - STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as
- [ContextVision – Information regarding dividend and reverse share split in Inify Laboratories](https://www.contextvision.se/contextvision-information-regarding-dividend-and-reverse-share-split-in-inify-laboratories/) - ContextVision AB ("ContextVision" or the "Company") will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB ("INIFY") to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around
- [ContextVision – new CFO appointed](https://www.contextvision.se/contextvision-new-cfo-appointed/) - Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the same role at Inify Laboratories, a spinoff from ContextVision. Mrs Linderoth will remain within the
- [INIFY Laboratories AB becomes an independent company](https://www.contextvision.se/inify-laboratories-ab-becomes-an-independent-company/) - STOCKHOLM – December 10, 2021 - ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company through a distribution of its shares to existing shareholders of ContextVision. The company will build
- [Join us at RSNA 2021 – virtual event, November 28 – December 1](https://www.contextvision.se/join-us-at-rsna-2021-virtual-event-november-28-december-1/) - Join us at RSNA 2021 – virtual event, November 28 – December 1 where you will be able to see our latest groundbreaking solutions in image enhancement.
- [Join us at ECR 2021 – online event, March 3 – 7](https://www.contextvision.se/join-us-at-ecr-2021-online-event-march-3-7/) - Will we be meeting at ECR 2021 this year? The exhibition will be an online event and you will be able to see our latest groundbreaking solutions in image enhancement.
- [Join us at RSNA 2020 – all-virtual event, November 29 – December 5](https://www.contextvision.se/rsna2020_virtual_event/) - Will we be meeting at RSNA this year? The exhibition will be an online event and you will be able to see our latest groundbreaking solutions in image enhancement.
- [Meet us at CMEF Autumn 2020](https://www.contextvision.se/meet-us-at-cmef-autumn-2020/) - Meet us at CMEF Autumn 2020, October 19th-22nd. National Exhibition and Convention Center (Shanghai) (NECC), China John Xie 谢家农 / Sales Manager. E-mail: john.xie@contextvision.com
- [Join us at ECR 2020, Summer Edition, July 15–19](https://www.contextvision.se/join-us-at-ecr-2020-summer-edition-july-15-19/) - Come and talk to our representatives about our product portfolio or to get a VIP demonstration. Booth 110 Expo X1, Austria Center Vienna, Bruno-Kreisky-Platz 1, 1220 Vienna, Austria.
- [Welcome to RSNA 2019, the 105th Scientific Assembly and Annual Meeting, December 1–5](https://www.contextvision.se/rsna2019/) - Come and talk to our representatives about our product portfolio or to get a VIP demonstration. Booth 7508 North Hall, McCormick Place, Chicago, USA.
- [Meet us at CMEF Autumn 2019](https://www.contextvision.se/meet-us-at-cmef-autumn-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Meet us at JFR 2019](https://www.contextvision.se/meet-us-at-jfr-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Meet us at ISUOG 2019](https://www.contextvision.se/meet-us-at-isuog-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Meet us at ESC Congress 2019](https://www.contextvision.se/esc-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Meet us at Artificial Intelligence in Cardiology, July 19-20, 2019](https://www.contextvision.se/ai-in-cardiology-2019/) - Meet us at Artificial Intelligence in Cardiology, July 19-20, 2019. The conference: Current Applications and Future of AI in Cardiology. InterContinental, San Francisco, California
- [Meet us at the 31st European Congress of Pathology in Nice (ECP 2019), 7–11 September 2019](https://www.contextvision.se/ecp2019nice/) - Come and talk to our representatives about our upcoming digital pathology portfolio.
- [Meet us at CMEF, May 14–17, 2019](https://www.contextvision.se/cmef2019/) - Meet us at CMEF, April 11–14, 2018, Shanghai, China. Hall 5.1, Booth D10. Contact us: John Xie 谢家农 / Sales Manager, phone +86 13 801 333 835, e-mail john.xie@contextvision.com
- [Meet us at AIUM, 6 - 10 April, 2019](https://www.contextvision.se/aium-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Meet us at ICE, Feb 17–19, 2019](https://www.contextvision.se/ice-2019/) - Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Visit ContextVision at ECR 2019, booth 111 (Expo X1) to see the latest in image enhancement](https://www.contextvision.se/ecr2019/) - At ECR 2019 ContextVision presents Altumira™, AI-powered image enhancement for digital radiography.
- [Visit ContextVision at RSNA 2018 (North Hall, booth #7208) to see latest in image enhancement](https://www.contextvision.se/rsna18/) - At RSNA 2018 ContextVision introduces Altumira™, AI-powered image enhancement for digital radiography.
- [Meet us at the 5th Digital Pathology & AI Congress in London, 6–7 December 2018](https://www.contextvision.se/digipathge/) - Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 22, London Heathrow Marriott Hotel.
- [Welcome to RSNA 2018, the 104th Scientific Assembly and Annual Meeting in Chicago, November 25–29](https://www.contextvision.se/rsna2018/) - Come and talk to our representatives about our product portfolio or to get a VIP demonstration. Booth 7208 North Hall, McCormick Place, Chicago, USA.
- [Meet us at CMEF in Shenzhen 2018](https://www.contextvision.se/meet-us-at-cmef-in-shenzhen-2018/) - Meet us at CMEF 2018 in Shenzhen, China from October 29 to November 1
- [Meet us at Medica 2018](https://www.contextvision.se/meet-us-at-medica-2018/) - Meet us at Medica 2018 in Düsseldorf, Germany from 12–15 November 2018.
- [Meet us at the 30th European Congress of Pathology in Bilbao, 8–12 September 2018](https://www.contextvision.se/ecp2018/) - ContextVision will attend the 30th European Congress of Pathology (ECP 2018) in Bilbao, Spain. Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 43, hall I + II on level -2 in the Euskalduna Conference Centre
- [Meet us at ECDP/NDP in Helsinki, 29th May – 1st June 2018](https://www.contextvision.se/meet-us-at-ecdp-ndp-in-helsinki-29th-may-1st-june-2018/) - Stand 04, Clarion Hotel Helsinki, Tyynenmerenkatu 2, 00220 Helsinki, Finland. Contact us: Lena Kajland Wilén / Director Business Unit Digital Pathology, phone: +46 70 629 07 84 or e-mail: lena.kw@contextvision.se
- [Meet us at CMEF, April 11–14, 2018](https://www.contextvision.se/cmef-2018/) - Meet us at CMEF, April 11–14, 2018, Shanghai, China. Hall 5.1, Booth D10. Contact us: John Xie 谢家农 / Sales Manager, phone +86 13 801 333 835, e-mail john.xie@contextvision.com
- [Meet us at AIUM, March 24–28, 2018](https://www.contextvision.se/aium-2018/) - Meet us at AIUM, March 24–28, 2018. New York Hilton Midtown, USA. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail william.mcginnis@contextvision.com.
- [Join us at ECR 2018](https://www.contextvision.se/join-us-at-ecr-2018/) - ContextVision will showcase the entire product portfolio including the two latest products, VolarView™ for handheld ultrasound devices and the Orthopedic Package for radiography.
- [Meet us at Arab Health 2018](https://www.contextvision.se/meet-us-arab-health-2018/) - Arab Health 2018 29 January - 01 February 2018 | 10:00 AM - 06:00 PM Dubai International Convention and Exhibition Centre https://www.arabhealthonline.com/en/Home.html ContextVision AB Stellan Heyerdahl / Director, OEM Sales Asia Klara Norra Kyrkogata 31 SE-111 22 Stockholm, Sweden Phone: +46 701 96 02 87 E-mail: stellan.heyerdahl@contextvision.se
- [Visit ContextVision at RSNA (North Hall B, booth #7208) to see latest in image enhancement](https://www.contextvision.se/contextvision-unveil-new-products-upgrades-rsna-2017/) - At this year’s Annual Meeting of RSNA, ContextVision will launch two new products, one serving the needs of handheld ultrasound users, and the other focused around the needs of the orthopedics imaging.
- [Join us at ISUOG 2017](https://www.contextvision.se/join-us-at-isuog-2017/) - Experience the impact of true-to-reality quality in medical imaging. Meet us at ISUOG in Vienna, Austria, September 16 – 19 / Booth #35
- [Join us at RSNA 2016](https://www.contextvision.se/join-us-at-rsna-2016/) - Experience the impact of true-to-reality quality in medical imaging. Meet us at RSNA, North – Hall B: 7208, Nov 27 – Dec 2, 2016.
- [Join us at ECR 2016](https://www.contextvision.se/join-us-at-ecr-2016/) - Meet us at ECR 2016. March 3–6, 2016. Hall X1, Booth #505. ContextVision’s image enhancement software helps doctors more accurately interpret results of Ultrasound, MRI, X-Ray and Mammography examinations. Every day. All over the world.
- [Join us at RSNA 2015](https://www.contextvision.se/join-us-at-rsna-2015/) - ContextVision’s image processing solutions provide the highest quality for accurate reading and diagnosis in Ultrasound, X-ray, MRI and Mammography. Every day. All over the world. LET US INTRODUCE YOU TO OUR LATEST COLLECTION OF IMAGE PROCESSING TOOLS. Meet us at RSNA 2015 / Booth #B6910 / Nov 29 – Dec 4 WE CAN’T WAIT TO
- [Join us at ISUOG 2015](https://www.contextvision.se/join-us-at-isuog-2015/) - GOPiCE® REALiCE® 3D/4D visualization – Views never before seen ContextVision’s sophisticated ultrasound portfolio opens up new dimensions for image enhancement – and new possibilities for women’s health. Delivering the highest possible image quality, in both 2D and 3D, it allows clinicians to make faster, more accurate diagnoses with a higher degree of confidence. See
- [Come and join us at CMEF 2015!](https://www.contextvision.se/come-and-join-us-at-cmef-2015/) - New Visualization – Approaching Reality Experience a new standard in image quality. With even sharper images, we have taken 3D/4D ultrasound imaging yet another step forward. Come see for yourself and discover our broad multimodality portfolio within image enhancement. Seeing is believing / CMEF 2015 / Booth H.6.2-Z08 / May 15 – 18 WE CAN’T
- [Join us at ECR 2015](https://www.contextvision.se/join-us-at-ecr-2015/) - New Visualization – Approaching Reality Experience a new standard in image quality. With even sharper images, we have taken 3D/4D ultrasound imaging yet another step forward. Come see for yourself and discover our broad multimodality portfolio within image enhancement. Seeing is believing / ECR 2015 / Expo E, Booth #505 / March 4 - 8
- [Join us at ISUOG 2014](https://www.contextvision.se/join-us-at-isuog-2014/) - Reality – as never seen before ContextVision is proud to introduce REALiCE, our new ultrasound package for obstetrics and gynecology. Experience unique views with clearer, highly realistic and in-depth visualization. Seeing is believing – come to booth 12 at ISUOG World Congress in Barcelona, Sep 14–17, and we’ll show you more. WE CAN’T WAIT TO SEE YOU!
- [让我们一起创建医学影像新规则](https://www.contextvision.se/让我们一起创建医学影像新规则/) - 在过去30年中，世界各地的临床医生一直依靠康泰瑞影（ContextVision）的先进影像增强软件所提供的卓越品质，在超声、X光、磁共振成像、乳腺X光成像、介入放射和CT成像领域从事工作。我们始终保持市场领先的技术优势，并通过增加新功能和改进现有功能推出了我们产品家族的最新成员：US PLUSView和GOPView Mammo2。 如果您想要了解如何从我们的医疗影像解决方案和专业技术受益，欢迎莅临4月17-20日在深圳会议展览中心举行的2014年中国国际医疗器械博览会（CMEF）第2展厅第M12展台，并与我们一起庆祝影像增强技术30周年庆典。 热烈期待与您的会面 I获取更多信息 | info@contextvision.se
- [Come and join us at CMEF 2014!](https://www.contextvision.se/join-us-at-cmef-2014/) - We are always keeping a step ahead of the market, we are now proud to present the latest highlights and new, improved features of our extensive product family: US PLUSView and GOPView Mammo2. Find out how you can benefit from our medical imaging solutions and expertise at CMEF 2014
- [ИЗОБРЕТЕМ СТАНДАРТЫ УЛУЧШЕНИЯ КАЧЕСТВА МЕДИЦИНСКИХ ИЗОБРАЖЕНИЙ ВМЕСТЕ!](https://www.contextvision.se/изобретем-стандарты-улучшения-качес/) - Всегда на шаг впереди, мы с гордостью представляем новейшие разработки и усовершенствованные характеристики расширенной продуктовой линейки: US PLUSView и GOPView Mammo2. Узнайте, какие возможности могут предоставить Вам наши решения, знания и опыт на Европейском Конгрессе Радиологов ECR, который состоится в Вене 7–10 марта 2014 года – приходите к нам на стенд №505 и присоединяйтесь к нам в праздновании 30-летия успешной работы в области оптимизации качества медицинских изображений!
- [Let us introduce our globally renowned family of image enhancement software](https://www.contextvision.se/let-us-introduce-our-globally-renowned-family-of-image-enhancement-software-2/) - Always keeping a step ahead of the market, we are now proud to present the latest highlights and new, improved features of our extensive product family: US PLUSView and GOPView Mammo2. Find out how you can benefit from our medical imaging solutions and expertise at ECR, booth #505, March 7–10, Vienna, 2014 – and join us in celebrating 30 successful years of image enhancement.
- [Let us introduce our globally renowned family of image enhancement software](https://www.contextvision.se/let-us-introduce-our-globally-renowned-family-of-image-enhancement-software/) - For the past 30 years, clinicians throughout the world have relied on the unsurpassed quality of ContextVision’s advanced image enhancement software within ultrasound, x-ray, magnetic resonance imaging, mammography, interventional radiology and computed tomography. Always keeping a step ahead of the market, we are now proud to present the latest highlights and new, improved features of our extensive product family: US PLUSView and GOPView Mammo2. Find out how you can benefit from our medical imaging solutions and expertise at RSNA, Hall B, booth #7010, December 1-6 2013 – and join us in celebrating 30 successful years of image enhancement.
- [让我们为您介绍  我们享誉全球的图像增强处理软件系列](https://www.contextvision.se/让我们为您介绍-我们享誉全球的图像增强处理软件/) - 瞳법혼30쾨쟁，各썹몹뒈돨줄눠努떼弩윳ContextVision邱쏵돨暠獗藤퓻뇹잿흡숭，쏵契낚、X窟、늚묾驪냥獗、鑒俚흗裙、썽흙렴欺뵨셕炬샙뙤꿔췄된쥴堵돨줄눠閭뙤。菱닒乖쳬뎌鹿윱，迦老괏넣懇끝쥴邱뒈貫。君瞳징路股놔야唐離劤묘콘돨끓틔溝죗US PLUSView뵨GOPView Mammo 2。쓴헝퀭黨2013쾨12墩1逞6휑밟줄RSNA,B반,7010뵀嵐憩，瞳컸쟁，퀭콘학먁肝돕ContextVision暠獗藤퓻썩엄렘갭못퀭던윱돨줄눠봤뇹。谿珂，乖쳬佳헙男헝퀭꽝속무鱇냥접30鷺쾨돨헤龍功삔。
- [让我们一起创建医学影像新规则](https://www.contextvision.se/cmef-invitation-ch/) - 体验影像增强技术领域的全新维度 随着影像变得立体，我们开启了一个全新的维度。康泰瑞影(ContextVision)最新3D/4D技术提升影像质量，
- [ECR 2013: Let’s reinvent the rules of medical imaging, together](https://www.contextvision.se/ecr-2013-lets-reinvent-the-rules-of-medical-imaging-together/) - Experience a New dimension within image enhancement When images become volumes, we open up new dimensions. ContextVision’s latest 3D/4D technology is already improving image quality and clinical decision making world-wide. Come see us at ECR and let us show you how you and your clients can benefit from this. Join us in Expo E, Booth #520
- [ECR 2013: Давайте вместе заново изобретать правила визуализации медицинских изображений!](https://www.contextvision.se/ecr-2013-russian-invitation/) - Откройте для себя новое измерение в улучшении качества изображения. Когда изображение становится объемным, мы оптимизируем визуализацию нового измерения. Новейшая технология ContextVision для улучшения качества 3D/4D изображений уже работает на международном рынке и предоставляет врачам по всему миру возможность оптимизировать работу для более точной постановки диагноза.
- [ECR 2013: 让我们一起创造医疗影像的未来](https://www.contextvision.se/ecr-2013-chinese-invitation/) - 먁肝努좟緞獗藤퓻세減離품懶돨쏵嵐 흔쏟，緞獗攣꼍흙힛郭왕쇌돨랙嵐뱀돛，劍攣蕨乖쳬嵐君놔홍劤돨왕쇌郭똑。Contextvision離劤3D/4D세減겉홍헷努欺暠獗醴좆뵨줄눠閭뙤彊틱股蕨劤돨멕똑。쓴헝퀭밟줄Contextvision돨嵐憩，꽝宅깻竟駱離老痰빵----줄눠閭뙤훙却角흔부權肝離劤세減杰던윱돨봤뇹돨。乖쳬퍅덤淪瞳ECR E世博会，520뵀嵐憩宅퀭宮앱。
- [Откройте для себя новое измерение в улучшении качества изображения](https://www.contextvision.se/откройте-для-себя-новое-измерение-в-ул/) - Откройте для себя новое измерение в улучшении качества изображения. Передовые технологии ContextVision применяются уже сейчас, позволяя оптимизировать качество 2D/3D/4D изображений и улучшить точность постановки диагноза во всем мире.
- [Experience a new dimension within image enhancement](https://www.contextvision.se/zdravookhraneniye-2012/) - ContextVision’s latest 2D/3D/4D technology is already improving image quality and clinical decision making world-wide. Come see us at Zdravookhraneniye and let us show you how you and your clients can benefit from this. Join us in Hall 2, Pavilion 2, Booth #22A34
- [Давайте вместе заново изобретать правила визуализации медицинских изображений!](https://www.contextvision.se/давайте-вместе-заново-изобретать-пра-2/) - Откройте для себя новое измерение в улучшении качества изображения. Когда изображение становится объемным, мы оптимизируем визуализацию нового измерения.
- [让我们一起创造医疗影像的未来](https://www.contextvision.se/让我们一起创造医疗影像的未来/) - 먁肝努좟緞獗藤퓻세減離품懶돨쏵嵐 흔쏟，緞獗攣꼍흙힛郭왕쇌돨랙嵐뱀돛，劍攣蕨乖쳬嵐君놔홍劤돨왕쇌郭똑。Contextvision離劤3D/4D세減
- [Let’s reinvent the rules of medical imaging, together](https://www.contextvision.se/lets-reinvent-the-rules-of-medical-imaging-together-2/) - When images become volumes, we open up new dimensions. ContextVision’s latest 3D/4D technology is already improving image quality and clinical decision making world-wide. Come see us at RSNA and let us show you how you and your clients can benefit from this.
- [Let’s reinvent the rules of medical imaging, together](https://www.contextvision.se/lets-reinvent-the-rules-of-medical-imaging-together/) - At this years ISUOG we are proud to present a new level of image quality within ultrasound – now available for OEMs worldwide and completely adaptable to all modern platforms. Join us in Hall E, Booth #22 to experience the cutting edge technology embedded in US PLUSView™ and GOPiCE® US. We are, as always, looking forward to your opinion and many interesting discussions! Don’t miss out on our demonstrations
- [让我们一起重塑医学影像的规则](https://www.contextvision.se/让我们一起重塑医学影像的规则/) - 在即将举行的ISUOG大会上，ContextVision隆重推出能够与当今各种平台相匹配的、 新一代的超声影像处理解决方案，供全球OEM厂商选择。 敬请光临Hall E 22号展台，体验最先进的US PLUSView和GOPiCE两款产品。 您的关注和评价将一如既往成为我们继续前进的动力！ 请不要错过精彩的演示
- [Давайте вместе заново изобретать правила визуализации медицинских изображений!](https://www.contextvision.se/давайте-вместе-заново-изобретать-пра/) - В этом году на конгрессе ISUOG мы с гордостью представляем новый уровень качества ультразвуковых изображений – теперь доступный для производителей комплектного оборудования по всему миру и совместимый со всеми современными платформами. Посетите наш стенд #22 в зале E, чтобы открыть для себя передовые технологии, внедренные в US PLUSView™ и GOPiCE® US. Мы, традиционно, ждем с нетерпением Ваших мнений и множества интересных дискуссий!

## Pages

- [ContextVision – Beyond Imaging](https://www.contextvision.se/) - We believe in long-term partnerships. Get to know us better!
- [The share](https://www.contextvision.se/theshare/) - The share The share ContextVision has been listed on the Oslo Børs since March 17th, 1997 (ticker code CONTX). All shares have equal rights and are freely transferable. Follow the development of the ContextVision share at Oslo Børs. View all ContextVision stock exchange releases at Oslo Børs NewsWeb. Investors contact For investor information and/or inquiries, please contact:Richard HallströmChief
- [Career](https://www.contextvision.se/career/)
- [Corporate Governance](https://www.contextvision.se/corporate-governance/) - Corporate governance Corporate governance ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law. Since 1997, the company is listed on the Oslo Stock Exchange under the ticker CONTX and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with
- [Board of directors](https://www.contextvision.se/boardofdirectors/) - Board of directors Board of directors Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec elementum erat in dui sollicitudin, at viverra magna vulputate. Ut gravida diam nisi, quis ullamcorper dui condimentum ac. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec elementum erat in dui sollicitudin, at viverra magna vulputate. Ut gravida diam nisi,
- [Management Team](https://www.contextvision.se/management-team/) - Management team Management team Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec elementum erat in dui sollicitudin, at viverra magna vulputate. Ut gravida diam nisi, quis ullamcorper dui condimentum ac. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec elementum erat in dui sollicitudin, at viverra magna vulputate. Ut gravida diam nisi, quis ullamcorper
- [General Meeting](https://www.contextvision.se/general-meeting/) - General Meeting General Meeting The General Meeting is the company’s supreme decision-making body. Notice of a General Meeting is distributed four to six weeks before the date of the meeting by announcement at the stock exchange and in Swedish press. The Articles of Association stipulate, and the Swedish Companies Act regulates the annual General Meeting
- [Overview](https://www.contextvision.se/overview/) - Overview Overview ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law. Since 1997, the company is listed on the Oslo Stock Exchange under the ticker CONTX and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with all applicable
- [Remuneration](https://www.contextvision.se/remuneration/) - Remuneration Remuneration Downloads Remuneration Report 2025 (Swedish) Download Remuneration Report 2025 (English) Download Remuneration Report 2024 (English) Download Remuneration Report 2024 (Swedish) Download Auditor’s Report (Swedish) Download Downloads Remuneration Report 2025 (Swedish) Download Remuneration Report 2025 (English) Download Remuneration Report 2024 (English) Download Remuneration Report 2024 (Swedish) Download Auditor’s Report (Swedish) Download
- [Financial calendar](https://www.contextvision.se/financial-calendar/) - Financial calendar Financial calendar The financial reports will be released in conjunction with the opening of Oslo Börs. A video presentation by CEO Gerald Pötzsch and CFO Richard Hallström, will be published on the same day for each quarterly report. For more details please contactRichard HallströmChief Financial OfficerE-mail: richard.hallstrom@contextvision.se The financial reports will be released in conjunction with the
- [ECR 2026](https://www.contextvision.se/ecr2026/)
- [Next-Gen Image Enhancement Technology](https://www.contextvision.se/next-gen/) - Next-Gen Image Enhancement Technology Next-Gen Image Enhancement Technology See More. Know more. ContextVision is the global market leader in image analysis and artificial intelligence — delivering organ and disease‑specific image enhancement that elevates clinical clarity, diagnostic confidence and workflow efficiency. Discover our capabilites Next-Gen Organ & Disease-Specific Portfolio Clinicians know best. ContextVision collaborates closely with both
- [Ultrasound](https://www.contextvision.se/ultrasound/) - Ultrasound At the forefront of ultrasound imaging Ultrasound At the forefront of ultrasound imaging Rivent™ 2D Rivent™ Mobile Rivent™ 3D MASLD setting Rivent™ 2D Rivent™ Mobile Rivent™ 3D MASLD setting ContextVision provides state-of-the-art image enhancement and visualization for Ultrasound. Through continuous development and innovative technology, ContextVision offers clients a leading position in diagnostic ultrasound. Our
- [Nomination Committee](https://www.contextvision.se/nomination-committee/) - Nomination Committee Nomination Committee Members of the nomination committeeOlof Sandén, Chairman of the board of directors.Martin SandbergMagne JordangerSven Günther-Hanssen AssignmentThe nomination committee shall prepare and present, to the annual general meeting 2026, proposals regarding electoral and remuneration issues and procedural issues for the appointment of a new nomination committee. Members of the nomination committeeOlof Sandén,
- [Contact](https://www.contextvision.se/contact/) - ContextVision around the world ContextVision around the world Sales China ContextVision AB / 康泰瑞影John Xie 谢家农 / Sales Director ChinaPhone: +86 13 801 333 835E-mail: john.xie@contextvision.com Americas ContextVision Inc.Lisa Ingle / Sales Director AmericasBusiness Director, ContextVision Inc.Phone: +1 585 505 3771E-mail: lisa.ingle@contextvision.com Asia ContextVision ABStellan Heyerdahl / Sales DirectorPhone: +46 701 96 02 87E-mail: stellan.heyerdahl@contextvision.com Europe ContextVision ABStellan Heyerdahl
- [Meet our Employees](https://www.contextvision.se/employees/) - Meet our employees The minds shaping our technology Meet our employees We want to add to that strength by employing talented individuals who are willing to work for a leading company dedicated to medical imaging and innovative technologies. In return, we will encourage you to develop and manage your career with us, in a stimulating
- [News](https://www.contextvision.se/news/) - News News Our latest news Our latest news
- [Solutions](https://www.contextvision.se/solutions/) - Carina Stenman, Ph.D., Clinical Specialist, talks about the significance of image quality in diagnostic ultrasound. Integration & support All products are designed for seamless integration. An SDK is delivered, the image processing library is a .dll file, and image quality and performance are controlled by parameter files. With a highly configurable design, products are customized for
- [Collateral](https://www.contextvision.se/collateral/) - Collateral Collateral Articles
- [Partnerships](https://www.contextvision.se/partnerships/) - Partnerships Partnerships The University of Washington (UW) The University of Washington (UW) and ContextVision have established a strategic partnership aimed at enhancing the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD). This collaboration focuses on developing advanced imaging biomarkers through the integration of artificial intelligence
- [Investor news](https://www.contextvision.se/investor-news/) - Investor news Investor news Investors contact For investor information and/or inquiries, please contact Richard HallströmChief Financial Officer E-mail: richard.hallstrom@contextvision.com Investors contact For investor information and/or inquiries, please contactRichard HallströmChief Financial OfficerE-mail: richard.hallstrom@contextvision.com
- [Financial reports](https://www.contextvision.se/financial-reports/) - Financial reports Financial reports Investors contact For investor information and/or inquiries, please contact Richard HallströmChief Financial Officer E-mail: richard.hallstrom@contextvision.com Investors contact For investor information and/or inquiries, please contactRichard HallströmChief Financial OfficerE-mail: richard.hallstrom@contextvision.com
- [Subscription](https://www.contextvision.se/subscription/) - Subscriptions Subscription Sign up by filling out the form and get all the latest news. Sign up by filling out the form and get all the latest news.
- [MFN TEST](https://www.contextvision.se/mfn-test/) - MFN TEST MFN TEST Release feed Subscribe Report archive
- [Technology](https://www.contextvision.se/technology/) - Technology Driven by innovation Technology Driven by innovation ContextVision is a company driven by innovation. Research is a fundamental part of our long-term strategy to create new and innovative products. In our research, we focus on knowledge buildup and technology exploration. By first freely exploring what technology can achieve, we can then match these possibilities
- [Committees](https://www.contextvision.se/committees/) - Committees Committees Audit Committee There is no specific audit committee within ContextVision. To comply with the rules of the Swedish Companies Act, the company has chosen to let the Board as a whole perform the tasks required of the Audit Committee. Remuneration Committee There is no specific remuneration committee within ContextVision. To comply with the
- [Data Quality](https://www.contextvision.se/data-quality/) - Data Quality Data Quality Beyond Imaging: The Transformation to Data Quality Building on more than 40 years of leadership in medical image enhancement, ContextVision is advancing its legacy through the transformation to Data Quality— a focused ultrasound program that leverages AI-powered image-enhancements to enable organ and disease specific quantitative imaging solutions to point-of-care ultrasound. The
- [Service](https://www.contextvision.se/service/) - Service A dedicated partner Service What sets us apart is our close collaboration with clients, allowing us to craft adapted solutions that are flexible, responsive and robust, perfectly aligned with their individual requirements. Our dedication goes beyond resolving immediate clinical challenges; we actively engage in strategic collaboration to anticipate and adapt to future industry trends.
- [Articles of Association](https://www.contextvision.se/articles-of-association/) - Articles of Association Articles of Association BOLAGSORDNING §1 Bolagets firma är ContextVision AB. Bolaget är publikt (publ). § 2 Bolaget skall bedriva utveckling, produktion, marknadsföring och försäljning av produkter för digitala bilder, i syfte att öka värdet av bilderna eller bildsekvenserna genom bildförbättring och bildanalys. § 3 Styrelsen skall ha sitt säte i Linköping. §
- [Auditors](https://www.contextvision.se/auditors/) - Auditors Auditors The auditor serves for a period of one year at a time and is elected at the annual general meeting. The auditor participates in a yearly board meeting in February. This occasion allows a review of any material changes in the company’s accounting principles and a report on any disagreement that may have
- [Cookie Policy](https://www.contextvision.se/cookie-policy/) - Cookie policy Cookie policy ContextVision AB (company reg. number 556377-8900) ("ContextVision") uses cookies on this website to make the website function properly, provide better user experience, and understand how the website performs. What are cookies? Cookies are small text files of information that are stored on your device, i.e. your computer, mobile phone, tablet, etc.,
- [Privacy Notice](https://www.contextvision.se/privacy-notice/) - Privacy notice Privacy notice Introduction This privacy notice (the “Privacy Notice”) applies to ContextVision AB’s, company registration number 556377-8900, (hereinafter referred to as “ContextVision”, “we” or “us”) processing of personal data when you or the company you represent is a customer, when you visit our website or otherwise engage with us such as apply for
- [X-ray](https://www.contextvision.se/xray/) - Daniel Alamidi, Product Manager for X-ray, describes ContextVision’s strengths and future focus for x-ray. Before and after Altumira™ processing Pull the slider left and right to see the difference before and after Altumira processing. Pull the slider left and right to see the difference before and after Altumira processing. Before and after Altumira™ processing Pull
- [Veterinary](https://www.contextvision.se/veterinary/) - Veterinary X-ray Excellent, stable, and robust image quality Veterinary X-ray Excellent, stable, and robust image quality The image enhancement solution for digital X-ray enables excellent image quality and robustness in daily use. Its high flexibility allows system manufacturers to easily meet a wide range of image quality preferences. The product can be optimized for all
- [Artificial intelligence](https://www.contextvision.se/ai/) - Artificial intelligence Transforming data into diagnostic power Artificial Intelligence Transforming data into diagnostic power With the new AI technology, we can develop machines to help humans, resulting in better treatment and more effective healthcare. ContextVision has made significant investments in artificial intelligence technology over the last decade. Today we have a R&D team with extensive
- [Contact](https://www.contextvision.se/404-page/) - Page not found (404) We apologize, but the page you are looking for cannot be found. It may have been moved, deleted, or the URL may have been entered incorrectly. Please try the following options: Check the URL for any errors. Return to our homepage. Use the search bar to find the content you are
- [Subscription](https://www.contextvision.se/subscription/thank-you/) - Subscriptions Subscription Thank you for your subscription. Thank you for your subscription.
- [Test](https://www.contextvision.se/test/)
- [About the company](https://www.contextvision.se/about-contextvision/) - Quality policy Product safety and effectiveness are of highest priority at ContextVision. ContextVision aims to fulfill the expectations and requirements from our customers and stakeholders, in compliance with applicable laws, regulations and standards. ContextVision operates continuously and systematically with improvements of products and processes to ensure the quality of our products, and to minimize risks
- [Investors](https://www.contextvision.se/investors/) - Investors news Add pay-off here Latest investor news
- [MRI](https://www.contextvision.se/mri/) - Magnetic Resonance Imaging Soft tissue contrast, superior noise reduction, and edge sharpness Magnetic Resonance Imaging Soft tissue contrast, superior noise reduction, and edge sharpness ContextVision’s image enhancement solution for MRI provides excellent image quality in all types of systems, from high end to low end. It can be optimized for all applications and sequence types,
- [Webcast](https://www.contextvision.se/webcast/) - Webcast Webcast
- [Research & Development](https://www.contextvision.se/research-development/) - Research & development Unlocking new dimensions in healthcare Research & development Unlocking new dimensions in healthcare We have been leaders in image enhancement for almost 30 years, and we intend to extend that leadership into medical imaging applications of the latest technologies within artificial intelligence. We have therefore significantly increased our R&D investments over the
- [Media kit](https://www.contextvision.se/mediakit/) - Media kit Media kit Press images and logotypes Logotype The ContextVision logos and symbols are available here for download in EPS and PNG formats. (1,5 Mb zip-file) Download logotype Images Photos of Dr. Dr. Gerald Pötzsch, the Chief Executive Officer of ContextVision, are available here for download in TIFF and JPG formats. (12 Mb zip-file) Download

## Before and After Slider

- [MASLD-specific setting 02](https://www.contextvision.se/?bafg=masld-specific-setting-02)
- [MASLD-specific setting 01](https://www.contextvision.se/?bafg=masld-specific-setting-01)
- [GOPView MRI2Plus processing](https://www.contextvision.se/?bafg=gopview-mri2plus-processing)
- [X-ray skull before-after](https://www.contextvision.se/?bafg=11195)
- [X-ray skull before-after](https://www.contextvision.se/?bafg=x-ray-skull-before-after)
- [Altumira scatter correction](https://www.contextvision.se/?bafg=altumira-scatter-correction)
- [](https://www.contextvision.se/?bafg=12215)
- [Rivent ultrasound before-after](https://www.contextvision.se/?bafg=rivent-ultrasound-before-after)
- [Altumira noise reduction](https://www.contextvision.se/?bafg=altumira-noise-reduction)

## Content Blocks

- [MRI Picture](https://www.contextvision.se/ct_content_block/mri-2/)
- [Webcast picture](https://www.contextvision.se/ct_content_block/webcast-picture/)
- [Investor News picture](https://www.contextvision.se/ct_content_block/investor-news-picture/)
- [Financial Report](https://www.contextvision.se/ct_content_block/financial-report/)
- [About ContextVision](https://www.contextvision.se/ct_content_block/about-contextvision/) - How does ContextVision collaborate with partners? Listen to Stellan Heyerdahl, Sales Director Asia, explaining the business model.
- [Contact to order US middle of page](https://www.contextvision.se/ct_content_block/contact-to-order-us-middle-of-page/) - Get an unique solution for your specific need Reach out to our sales managers for a leading position in diagnostic imaging. Get in touch Get an unique solution for your specific need Reach out to our sales managers for a leading position in diagnostic imaging. Get in touch
- [Contact to order](https://www.contextvision.se/ct_content_block/contact-to-order/) - Get an unique solution for your specific need Reach out to our sales managers for a leading position in diagnostic imaging. Get in touch Get an unique solution for your specific need Reach out to our sales managers for a leading position in diagnostic imaging. Get in touch
- [Hook blocksy:single:content:top](https://www.contextvision.se/ct_content_block/hook-blocksysinglecontenttop-2/)
- [Hook blocksy:single:content:top](https://www.contextvision.se/ct_content_block/hook-blocksysinglecontenttop/)
- [Service & partnership Picture](https://www.contextvision.se/ct_content_block/xray-2-2-2/)
- [Solutions Picture](https://www.contextvision.se/ct_content_block/xray-2-2/)
- [Service & partnership](https://www.contextvision.se/ct_content_block/service/) - What sets our products apart is our close collaboration with clients, allowing us to craft adapted solutions that perfectly align with their individual requirements. Explore further details about our collaborative approach
- [X-ray Picture](https://www.contextvision.se/ct_content_block/xray-2/)
- [Ultrasound Picture](https://www.contextvision.se/ct_content_block/picture-for-ultrasound/)
- [Veterinary Picture](https://www.contextvision.se/ct_content_block/veterinary-picture/)
- [About CoV – Stellan](https://www.contextvision.se/ct_content_block/about-cov-stellan/)
- [Image enhancement picture](https://www.contextvision.se/ct_content_block/image-enhancement-picture/)
- [GDPR](https://www.contextvision.se/ct_content_block/gdpr/) - GDPR ContextVision has developed and implemented a Policy to ensure compliance to the General Data Protection Regulations, GDPR. This is based on a respect for the personal integrity of our customers and partners and it serves as a guideline to our employees for how to handle data governed by the new regulations.
- [Subscribe Cision](https://www.contextvision.se/ct_content_block/subscribe-cision/)
- [R&D Picture](https://www.contextvision.se/ct_content_block/r-2/)
- [Contact Foot menu](https://www.contextvision.se/ct_content_block/contact-foot-menu/) - Holländargatan 13, 2 trSE-111 36 Stockholm, SwedenPhone: +46 8 750 35 50E-mail: info@contextvision.com
- [Products for MRI](https://www.contextvision.se/ct_content_block/mri/)
- [Subscription](https://www.contextvision.se/ct_content_block/subscription/)
- [Empty](https://www.contextvision.se/ct_content_block/no/)

## Events

- [Join us at CMEF 2026](https://www.contextvision.se/calendar/join-us-at-cmef-2026/) - Beyond imaging – AI-powered solutions enabling precision diagnosis. Visit our booth at CMEF 2025 to discuss how we can transform the future of healthcare – together.
- [Join us RSNA 2026](https://www.contextvision.se/calendar/join-us-rsna-2026/) - Beyond imaging – AI-powered solutions enabling precision diagnosis. Visit our booth at CMEF 2025 to discuss how we can transform the future of healthcare – together.

## Categories

- [Uncategorized](https://www.contextvision.se/category/uncategorized/)
- [ContextVision](https://www.contextvision.se/category/contextvision/)
- [Home](https://www.contextvision.se/category/home/)
- [News](https://www.contextvision.se/category/news/)
- [Financial reports](https://www.contextvision.se/category/financial-reports/)
- [Annual reports](https://www.contextvision.se/category/financial-reports/annual-reports/)
- [Investor news](https://www.contextvision.se/category/investor-news/)
- [OEM](https://www.contextvision.se/category/oem/)
- [Annual General Meeting](https://www.contextvision.se/category/annual-general-meeting/)
- [Digital Pathology](https://www.contextvision.se/category/digital-pathology/)
- [Medical Imaging](https://www.contextvision.se/category/medical-imaging/)
- [ContextVision General](https://www.contextvision.se/category/contextvision-general/)
- [Bolagshandel](https://www.contextvision.se/category/bolagshandel/)
- [Primary Insider Transactions](https://www.contextvision.se/category/primary-insider-transactions/)
- [Invitations](https://www.contextvision.se/category/invitation/)
- [Webcast](https://www.contextvision.se/category/presentations/)
- [Articles](https://www.contextvision.se/category/articles/)

## Tags

- [2D/3D/4D](https://www.contextvision.se/tag/2d3d4d/)
- [GOPiCE US](https://www.contextvision.se/tag/gopice-us/)
- [ISUOG](https://www.contextvision.se/tag/isuog/)
- [Ultrasound](https://www.contextvision.se/tag/ultrasound/)
- [US PLUSView](https://www.contextvision.se/tag/us-plusview/)
- [RSNA](https://www.contextvision.se/tag/rsna/)
- [Add-On Modules](https://www.contextvision.se/tag/add-on-modules/)
- [ECR](https://www.contextvision.se/tag/ecr/)
- [GOPiCE MR](https://www.contextvision.se/tag/gopice-mr/)
- [GOPView iRVUltra](https://www.contextvision.se/tag/gopview-irvultra/)
- [GOPView MAMMO2](https://www.contextvision.se/tag/gopview-mammo2/)
- [GOPView MRI2Plus](https://www.contextvision.se/tag/gopview-mri2plus/)
- [GOPView XR2Plus](https://www.contextvision.se/tag/gopview-xr2plus/)
- [digipathge](https://www.contextvision.se/tag/digipathge/)
- [digital pathology](https://www.contextvision.se/tag/digital-pathology/)
- [INIFY](https://www.contextvision.se/tag/inify/)
- [Altumira](https://www.contextvision.se/tag/altumira/)
- [radiology](https://www.contextvision.se/tag/radiology/)
- [RSNA2018](https://www.contextvision.se/tag/rsna2018/)
- [RSNA18](https://www.contextvision.se/tag/rsna18/)
- [ECR 2019](https://www.contextvision.se/tag/ecr-2019/)
- [ICE](https://www.contextvision.se/tag/ice/)
- [ECR2020](https://www.contextvision.se/tag/ecr2020/)
- [RSNA2020](https://www.contextvision.se/tag/rsna2020/)